Top

BMC Neurology

Published in:

Open Access 01-12-2023 | Multiple Sclerosis | Research

Incidence and prevalence of neurological disorders in the United Arab Emirates: a systematic review

Authors: Hani T. S. Benamer, Tom Loney

Published in: BMC Neurology | Issue 1/2023

Abstract

Background/Objectives

The United Arab Emirates (UAE) is a rapidly developing country. With the increase in average life-expectancy, high rates of consanguinity, and the adoption of a Western lifestyle, the burden of neurological disorders is expected to increase over the next few decades. Despite the importance of neurological disorders, there has not been a systematic review of published studies on the epidemiology of neurological disorders in the UAE.

Methods

We searched for studies of incidence and/or prevalence of neurological disorders in the UAE published in English in MEDLINE, Google Scholar, Embase, and Scopus databases with no date restrictions up until 01 October 2023. Two authors independently assessed abstracts and full texts of possibly relevant papers, followed by data extraction from studies satisfying the eligibility criteria.

Results

Eight articles (N = 2067 patients) were included, half reported incidence and prevalence of multiple sclerosis, with an average crude prevalence 56/100,000 and related demyelinating disorders. Others were related to headache, meningitis, cerebral venous thrombosis, and brain tumours.

Conclusion

There is a distinct lack of data on the epidemiology of different neurological diseases in the UAE. Large population-based studies, ideally longitudinal, are required to provide accurate and reliable estimates of the incidence and prevalence of neurological disorders to help inform healthcare capacity planning.

Available only for authorised users

Fact sheet - The Official Portal of the UAE Government. https://u.ae/en/about-the-uae/fact-sheet. Accessed 15 Apr 2022.

Loney T, Aw T-C, Handysides DG, Ali R, Blair I, Grivna M, et al. An analysis of the health status of the United Arab Emirates: the “Big 4” public health issues. Glob Health Action. 2013;6:20100.CrossRefPubMed

GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97. https://doi.org/10.1016/S1474-4422(17)30299-5.

al-Gazali LI, Bener A, Abdulrazzaq YM, Micallef R, al-Khayat AI, Gaber T. Consanguineous marriages in the United Arab Emirates. J Biosoc Sci. 1997;29(4):491–7. https://doi.org/10.1017/s0021932097004914.

Shah SM, Loney T, Dhaheri SA, Vatanparast H, Elbarazi I, Agarwal M, et al. Association between acculturation, obesity and cardiovascular risk factors among male South Asian migrants in the United Arab Emirates–a cross-sectional study. BMC Public Health. 2015;15:204.CrossRefPubMedPubMedCentral

Shah SM, Loney T, Sheek-Hussein M, El Sadig M, Al Dhaheri S, El Barazi I, et al. Hypertension prevalence, awareness, treatment, and control, in male South Asian immigrants in the United Arab Emirates: a cross-sectional study. BMC Cardiovasc Disord. 2015;15:30.CrossRefPubMedPubMedCentral

Shah SM, Jaacks LM, Al-Maskari F, Al-Kaabi J, Aziz F, Soteriades E, et al. Association between duration of residence and prevalence of type 2 diabetes among male South Asian expatriate workers in the United Arab Emirates: a cross-sectional study. BMJ Open. 2020;10:e040166.CrossRefPubMedPubMedCentral

Shah SM, Ali R, Loney T, Aziz F, ElBarazi I, Al Dhaheri S, et al. Prevalence of diabetes among migrant women and duration of residence in the United Arab Emirates: a cross sectional study. PLoS ONE. 2017;12:e0169949.CrossRefPubMedPubMedCentral

Abdulle A, Alnaeemi A, Aljunaibi A, Al Ali A, Al Saedi K, Al Zaabi E, et al. The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals. BMC Public Health. 2018;18:101.CrossRefPubMedPubMedCentral

10.

International Diabetes Federation. IDF Diabetes Atlas. 10th ed; 2021. https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf.

11.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12. https://doi.org/10.1016/j.jclinepi.2009.06.005.

12.

Perera S, Eisen R, Bawor M, Dennis B, de Souza R, Thabane L, et al. Association between body mass index and suicidal behaviors: a systematic review protocol. Syst Rev. 2015;4:52.CrossRefPubMedPubMedCentral

13.

Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai. United Arab Emirates Int J Neurosci. 2011;121:393–8.PubMed

14.

Schiess N, Huether K, Fatafta T, Fitzgerald KC, Calabresi PA, Blair I, et al. How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates. Mult Scler Relat Disord. 2016;9:73–9.CrossRefPubMed

15.

Ismail FY, Gordon-Lipkin E, Huether K, Blair I, Szólics M, Alsaadi T, et al. Pediatric multiple sclerosis in the United Arab Emirates: characteristics from a multicenter study and global comparison. J Child Neurol. 2018;33:422–7.CrossRefPubMed

16.

Holroyd KB, Aziz F, Szolics M, Alsaadi T, Levy M, Schiess N. Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study. Clin Exp Neuroimmunol. 2018;9:155–61.CrossRefPubMedPubMedCentral

17.

Dash N, Ameen AS, Sheek-Hussein MM, Smego RA. Epidemiology of meningitis in Al-Ain, United Arab Emirates, 2000–2005. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2007;11:309–12.

18.

Sarathchandran P, Farooq S, Dar J, Khan M, AlRukn S. Frequency of Cerebral Venous Thrombosis in Dubai, UAE–A Multicenter. Retrospective Study Ann Neurosci. 2021;28:122–8.CrossRefPubMed

19.

Khan S, Kambris MEK, AlShamsi ET. Epidemiology of brain tumors in the United Arab Emirates: a National Registry Cross-sectional Study. BMC Neurol. 2020;20:301.CrossRefPubMedPubMedCentral

20.

Bener A, Uduman SA, Qassimi EMA, Khalaily G, Sztriha L, Kilpelainen H, et al. Genetic and environmental factors associated with migraine in schoolchildren. Headache J Head Face Pain. 2000;40:152–7.CrossRef

21.

Etemadifar M, Nikanpour Y, Neshatfar A, Mansourian M, Fitzgerald S. Incidence and prevalence of multiple sclerosis in persian gulf area: a systematic review and meta-analysis. Mult Scler Relat Disord. 2020;40:101959.CrossRefPubMed

22.

Benamer HTS, Ahmed ESM, Al-Din AS, Grosset DG. Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci. 2009;278:1–4.CrossRefPubMed

23.

MS International Federation. Atlas of MS. 3rd ed; 2020. https://www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf.

24.

GBD 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(3):269–85. https://doi.org/10.1016/S1474-4422(18)30443-5.

25.

Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014;83:1022–4.CrossRefPubMedPubMedCentral

26.

Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA. Multiple sclerosis epidemiology in East Asia, South East asia and south asia: a systematic review. Neuroepidemiology. 2016;46:209–21.CrossRefPubMed

27.

Maxion-Bergemann S, Windisch R. Epidemiology of multiple sclerosis: literature review for prevalence and trend over time in 5 European countries and Canada. Value Health. 2017;20:A719.CrossRef

28.

Sharma K, Bittner F, Kamholz J. Epidemiology of multiple sclerosis in the United States. Neurology. 2018;90(15 Supplement)P1.140.

29.

GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. https://doi.org/10.1016/S1474-4422(21)00252-0.

30.

GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(4):357–75. https://doi.org/10.1016/S1474-4422(18)30454-X. Erratum in: Lancet Neurol. 2019;18(5):e4.

31.

GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954–76. https://doi.org/10.1016/S1474-4422(18)30322-3. Erratum in: Lancet Neurol. 2021;20(12):e7.

32.

GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939–53. https://doi.org/10.1016/S1474-4422(18)30295-3. Erratum in: Lancet Neurol. 2021;20(12):e7.

Title: Incidence and prevalence of neurological disorders in the United Arab Emirates: a systematic review
Authors: Hani T. S. Benamer
Tom Loney
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Multiple Sclerosis
Meningitis
Published in: BMC Neurology / Issue 1/2023
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-023-03446-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incidence and prevalence of neurological disorders in the United Arab Emirates: a systematic review

Abstract

Background/Objectives

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background/Objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

The increasing role of electronic media in headache

Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson’s: a study protocol

Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease

Clinical presentations and treatment outcomes of Hashimoto encephalopathy at Siriraj Hospital – Thailand’s largest national tertiary referral center

Computed tomography derived cervical fat-free muscle fraction as an imaging-based outcome marker in patients with acute ischemic stroke: a pilot study